Given that CD30 positivity is observed in a significant proportion of EBV+ NT/NKCL cases [6], it can be challenging to distinguish it from ALK-negative anaplastic large cell lymphoma (ALCL). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.